GGHC
Gilder Gagnon Howe & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-243,836
| Closed | -$20.2M | – | 280 |
|
2016
Q4 | $20.2M | Sell |
243,836
-199,870
| -45% | -$16.6M | 0.4% | 68 |
|
2016
Q3 | $41.1M | Sell |
443,706
-17,983
| -4% | -$1.66M | 0.71% | 47 |
|
2016
Q2 | $35.9M | Sell |
461,689
-9,487
| -2% | -$738K | 0.71% | 47 |
|
2016
Q1 | $38.9M | Sell |
471,176
-9,220
| -2% | -$760K | 0.76% | 33 |
|
2015
Q4 | $50.3M | Sell |
480,396
-4,766
| -1% | -$499K | 0.81% | 31 |
|
2015
Q3 | $51.1M | Sell |
485,162
-141,338
| -23% | -$14.9M | 0.81% | 34 |
|
2015
Q2 | $85.7M | Sell |
626,500
-289,936
| -32% | -$39.7M | 1.13% | 25 |
|
2015
Q1 | $114M | Sell |
916,436
-146,826
| -14% | -$18.3M | 1.59% | 16 |
|
2014
Q4 | $96.1M | Sell |
1,063,262
-25,748
| -2% | -$2.33M | 1.43% | 22 |
|
2014
Q3 | $78.6M | Sell |
1,089,010
-12,714
| -1% | -$917K | 1.14% | 22 |
|
2014
Q2 | $68.5M | Sell |
1,101,724
-3,886
| -0.4% | -$242K | 0.91% | 28 |
|
2014
Q1 | $75.4M | Sell |
1,105,610
-23,125
| -2% | -$1.58M | 1.03% | 28 |
|
2013
Q4 | $79.4M | Sell |
1,128,735
-132,637
| -11% | -$9.33M | 1.13% | 27 |
|
2013
Q3 | $91M | Sell |
1,261,372
-26,240
| -2% | -$1.89M | 1.42% | 19 |
|
2013
Q2 | $71.8M | Buy |
+1,287,612
| New | +$71.8M | 1.35% | 21 |
|